06 December 2011
Generics Announces Positive Results From Phase IIa Cancer Cachexia Study
31 March 2011
Generics Closes $10 Million Investment Round07 February 2011
Phase 1 Clinical Trial Completed With APD515 For Xerostomia06 January 2011
Generics Starts Clinical Trial With APD515 For Xerostomia06 January 2011
New Website Launched